Cargando…

Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?

PURPOSE OF REVIEW: To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. RECENT FINDINGS: The design and scale-up of multidisciplinary care models that engage, retain, and treat individuals with HIV, HCV, and OUD are critical to preventing co...

Descripción completa

Detalles Bibliográficos
Autores principales: Rich, Katherine M., Bia, Joshua, Altice, Frederick L., Feinberg, Judith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003996/
https://www.ncbi.nlm.nih.gov/pubmed/29774442
http://dx.doi.org/10.1007/s11904-018-0396-x
_version_ 1783332443475935232
author Rich, Katherine M.
Bia, Joshua
Altice, Frederick L.
Feinberg, Judith
author_facet Rich, Katherine M.
Bia, Joshua
Altice, Frederick L.
Feinberg, Judith
author_sort Rich, Katherine M.
collection PubMed
description PURPOSE OF REVIEW: To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. RECENT FINDINGS: The design and scale-up of multidisciplinary care models that engage, retain, and treat individuals with HIV, HCV, and OUD are critical to preventing continued spread of HIV and HCV. We identified 17 models within primary care (N = 3), HIV specialty care (N = 5), opioid treatment programs (N = 6), transitional clinics (N = 2), and community-based harm reduction programs (N = 1), as well as two emerging models. SUMMARY: Key components of such models are the provision of (1) medication-assisted treatment for OUD, (2) HIV and HCV treatment, (3) HIV pre-exposure prophylaxis, and (4) behavioral health services. Research is needed to understand differences in effectiveness between co-located and fully integrated care, combat the deleterious racial and ethnic legacies of the “War on Drugs,” and inform the delivery of psychiatric care. Increased access to harm reduction services is crucial. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11904-018-0396-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6003996
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-60039962018-07-02 Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? Rich, Katherine M. Bia, Joshua Altice, Frederick L. Feinberg, Judith Curr HIV/AIDS Rep The Global Epidemic (SH Vermund, Section Editor) PURPOSE OF REVIEW: To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. RECENT FINDINGS: The design and scale-up of multidisciplinary care models that engage, retain, and treat individuals with HIV, HCV, and OUD are critical to preventing continued spread of HIV and HCV. We identified 17 models within primary care (N = 3), HIV specialty care (N = 5), opioid treatment programs (N = 6), transitional clinics (N = 2), and community-based harm reduction programs (N = 1), as well as two emerging models. SUMMARY: Key components of such models are the provision of (1) medication-assisted treatment for OUD, (2) HIV and HCV treatment, (3) HIV pre-exposure prophylaxis, and (4) behavioral health services. Research is needed to understand differences in effectiveness between co-located and fully integrated care, combat the deleterious racial and ethnic legacies of the “War on Drugs,” and inform the delivery of psychiatric care. Increased access to harm reduction services is crucial. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11904-018-0396-x) contains supplementary material, which is available to authorized users. Springer US 2018-05-17 2018 /pmc/articles/PMC6003996/ /pubmed/29774442 http://dx.doi.org/10.1007/s11904-018-0396-x Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle The Global Epidemic (SH Vermund, Section Editor)
Rich, Katherine M.
Bia, Joshua
Altice, Frederick L.
Feinberg, Judith
Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
title Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
title_full Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
title_fullStr Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
title_full_unstemmed Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
title_short Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
title_sort integrated models of care for individuals with opioid use disorder: how do we prevent hiv and hcv?
topic The Global Epidemic (SH Vermund, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003996/
https://www.ncbi.nlm.nih.gov/pubmed/29774442
http://dx.doi.org/10.1007/s11904-018-0396-x
work_keys_str_mv AT richkatherinem integratedmodelsofcareforindividualswithopioidusedisorderhowdowepreventhivandhcv
AT biajoshua integratedmodelsofcareforindividualswithopioidusedisorderhowdowepreventhivandhcv
AT alticefrederickl integratedmodelsofcareforindividualswithopioidusedisorderhowdowepreventhivandhcv
AT feinbergjudith integratedmodelsofcareforindividualswithopioidusedisorderhowdowepreventhivandhcv